President Trump spent four days moving from accepting the midterms to rejecting them. On Nov. 6 he told reporters in the Oval Office that “our elections are so crooked, you have no idea,” and on Truth Social demanded that votes cast for two minor Alaska candidates be handed to the incumbent Republican senator. On Nov. 9 he asked whether anyone “really believe[s] that this Election was honest” — days after telling the New York Times on election night that he was “absolutely willing” to accept the outcome. The count is not the contested part of this story. What is contested is what a 54-seat Senate and a 252-seat House can be expected to do with executive tariff authority in 2027.
House seats held by Democrats
252
of 435; Republicans 162 — NBC News live results, Nov. 9, 2026
Senate seats held by Democrats
54
of 100; Republicans 44, with seven seats flipped — Guardian live results, Nov. 4, 2026
Alaska Senate race, still uncalled
48.2%
Mary Peltola 48.2% against Dan Sullivan 47.9%, as of Nov. 9, 2026
Treasury borrowing, Oct.–Dec. 2026
$618B
announced Nov. 2, 2026; $800B expected in Jan.–Mar. 2027
Default Section 232 duty on patented drugs
100%
in force since Jul. 31, 2026; 20% for a qualifying onshoring plan
Average statutory tariff rate
11.8%
Yale Budget Lab, The State of U.S. Tariffs, November 2026
Nov. 3–9, 2026
The President Disowned the Result He Said He Would Accept
Every element of the certification fight is procedural rather than evidentiary. No court has accepted a fraud theory, and the Justice Department's Alaska suit failed on jurisdiction, standing and the ballot-secrecy problems of its proposed remedy — not on any finding about the count. What the President is actually pressing is a political allocation: that votes for two minor Alaska candidates, worth a few points of a ballot the incumbent is losing by roughly three tenths of a point, should be handed to him. This is a demand about who counts, not about whether the count was right.
- Oct. 27, 2026 — Says he will accept the midterm results only if they are “honest,” echoing language he used after the 2020 election.
- Nov. 3 — Election night: tells the New York Times he is “absolutely willing” to accept the results and expects to “work something out” with Democrats.
- Nov. 6 — Oval Office: “Our elections are so crooked, you have no idea.” On Truth Social he demands that minor-candidate votes in Alaska go to the “REAL Dan Sullivan”.
- Nov. 1 — A federal judge throws out the Justice Department's Alaska certification suit; the department files a notice of appeal the same day.
- Nov. 9 — Truth Social: “Does anybody really believe that this 'Election' was honest. How could the Polls be so wrong?”
| Race | Count as reported | What is unresolved |
|---|---|---|
| Alaska Senate | Mary Peltola 48.2%; Dan Sullivan 47.9% | Minor candidates hold the balance; the race had not been called as of Nov. 9, 2026 |
| Mississippi Senate | Scott Colom ahead of incumbent Cindy Hyde-Smith by 1,724 votes | Only a handful of ballots remained to be counted |
The mechanics
Certification Is a Court Process, Not a Negotiating Table
On Nov. 1 Judge Sharon Gleason dismissed the Alaska suit, finding that the government had not shown how delaying certification would redress an injury, offered no workable plan to segregate ballots while preserving ballot secrecy, and collided with the Supreme Court's caution against changing election rules close to an election. The dismissal was without prejudice, but the court refused leave to amend as futile, and the department filed a notice of appeal to the Ninth Circuit. The executive branch's certification weapon has failed once on procedure and must now win on appeal.
For congressional seats the counting arithmetic runs through the chambers themselves rather than an electoral count: a contested House race is decided by the House, and a contested Senate race by the Senate — the Senate that the Alaska result would itself compose. That self-referential structure is why certification gets settled by party arithmetic long before it gets settled by evidence. Alaska is the last uncalled Senate race, and the body that must seat its winner is the body the result creates.
| Stage | Date | Who acts | What moves |
|---|---|---|---|
| State certification, Alaska Senate | Uncalled as of Nov. 9, 2026 | Alaska election officials | Whether a contested seat is seated or litigated |
| Justice Department appeal | Notice filed Nov. 1, 2026 | Ninth Circuit | Whether the certification fight survives |
| Congress seated | Jan. 3, 2027 | 120th Congress | Who hears the Alaska contest |
| Electoral vote count | Jan. 6, 2027 | Joint session | Statutory date; no congressional seats at stake |
| Prediction-market fallback | Feb. 1, 2027 | Contract settlement rules | Party of the president pro tempore if no media consensus |
Prediction markets are where a contested certification could still bite, and the mechanics are specific. Kalshi's Senate-control contract names congress.gov as its designated source and pays out early once at least four of eight designated media outlets agree with none contradicting; if no consensus forms, settlement falls back to the party of the president pro tempore on Feb. 1, 2027. Polymarket resolves on official state and congressional sources plus a consensus of credible reporting, with a two-hour challenge window. The market's own record shows how fast this repriced: the odds of a House impeachment before July 1, 2027 jumped from 43.8% at 3 a.m. on Nov. 3 to 65% within hours of the result.
The tariff wall
Section 232 Is the Wall — and It Is the Hardest Thing a Blue Sweep Can Undo
The wall that matters in 2027 is not the one the President built with emergency powers; it is the one rebuilt after the courts took those powers away. The Supreme Court held on Feb. 20, 2026 that the International Emergency Economic Powers Act does not authorize tariffs, and the 10% global surcharge that replaced it under Section 122 was declared invalid by the Court of International Trade on May 7, 2026, with the appeal still pending. So the regime was rebuilt on Section 232, Section 301 and Section 338, and the average statutory tariff rate now stands at 11.8%. Every dollar of that wall now rests on statutes Congress wrote and the President administers.
| Sector | Headline duty | In force since | Statute |
|---|---|---|---|
| Patented pharmaceuticals | 100%, or 20% with a qualifying onshoring plan | Jul. 31, 2026 | Section 232 |
| Steel articles | 25%–50% by annex tier | Mar. 12, 2025 | Section 232 |
| Aluminum articles | 25%–50% by annex tier | Mar. 12, 2025 | Section 232 |
| Copper articles | 50%, or 25% on derivatives | Aug. 1, 2025 | Section 232 |
| Autos and parts | 25%, lower under country deals | Apr. 3, 2025 | Section 232 |
| Medium and heavy trucks, parts | 25% | Nov. 1, 2025 | Section 232 |
| Advanced computing chips | 25%, with U.S. use carve-outs | Jan. 15, 2026 | Section 232 |
| Softwood timber and lumber | 10% | Oct. 14, 2025 | Section 232 |
| Canadian vehicles, alcohol, dairy | 50% | Aug. 22, 2026 | Section 338 |
| Forced-labor imports | 10%–12.5% by country | Jul. 24, 2026 | Section 301 |
Section 232 headline duty rates by sector
Headline rates as imposed; derivative goods are tiered from 10% to 50% according to U.S. metal content.
Unit: % ad valorem
Patented drugs
100%
Steel
50%
Aluminum
50%
Copper
50%
Autos and parts
25%
Trucks and parts
25%
Advanced chips
25%
Lumber
10%
Buses
10%
The arithmetic of repeal is worse than it looks. Tariffs are mandatory revenue, so removing them inside a reconciliation bill raises the deficit and collides with the statutory pay-as-you-go budget rule unless offset elsewhere; a standalone repeal needs 60 votes in a Senate where 54 Democrats sit; and the Section 232 review route — a finding reported to Congress before it takes effect, which Congress can disapprove by concurrent resolution — runs straight into a presidential veto. Overriding that veto takes two-thirds in both chambers: 67 of 100 senators and 290 of 435 representatives. That is 13 Republican senators and 38 Republican representatives on top of a unified Democratic majority.
The encouraging precedent for free traders is that the judiciary will strike executive tariffs — IEEPA is gone and Section 122 is under appeal. The inconvenient precedent is that the statute the courts have not touched is the one carrying the wall. Section 232 is Congress's own delegation, and its findings are defended with a national-security rationale that courts have historically deferred to. A Democratic Congress is therefore far more likely to review the wall than to remove it, and review has a different kind of teeth: each determination's file returns to committee, where hearings and subpoenas can reshape the record before any floor vote is taken.
- Open the Section 232 review file: hearings on the semiconductor, pharmaceutical and metals determinations, with subpoena power over the agencies that wrote them.
- Table disapproval resolutions: a concurrent resolution disapproving a specific finding, which the President will veto — so the test becomes whether 13 Republican senators defect.
- Trade the funding calendar for leverage: the Dec. 11 continuing resolution is a vehicle the President must sign or veto, and a veto is a shutdown conversation the White House would rather not open before the inauguration.
- Push domestic capacity, not repeal: credits, permitting and procurement can be changed inside reconciliation without touching the duty revenue that the budget rules protect.
Upstream
The Wall Is Already in the Upstream Earnings
The cleanest evidence that the Section 232 wall is real comes from the companies it shelters. Nucor reported third-quarter revenue of $11.25 billion, up 32% year over year, with gross margin widening to 20.7% from 13.9% a year earlier. Freeport-McMoRan ran a 31.2% operating margin on $7.55 billion of copper revenue in the September quarter, and Century Aluminum converts the same protection into a 29.7% trailing net margin on $3.0 billion of sales at 3.0 times enterprise value to EBITDA. The duty widened margins far more than the commodity cycle did.
| Company | Duty that pays it | Latest reported | Where the stock sits |
|---|---|---|---|
| Nucor | Steel articles at 25%–50% | Q3 2026 revenue $11.25B, +32% YoY; gross margin 20.7% | $244.97, 15% below its 52-week high; 8.8x EV/EBITDA |
| Century Aluminum | Aluminum articles at 25%–50% | Trailing net margin 29.7%; net cash; 3.0x EV/EBITDA | $33.47, 52% below its 52-week high |
| Freeport-McMoRan | Copper articles at 50%, 25% on derivatives | Q3 2026 operating margin 31.2%; trailing revenue $26.4B | $62.33, 22% below its 52-week high; 9.9x EV/EBITDA |
The gap between earnings and share prices is the story. Domestic hot-rolled coil has climbed about 31% since mid-2025 to $1,124.75 a net ton by late June, and Nucor held its consumer spot price at $1,135 a ton in the week of July 20, 2026 — yet the shares are still 15% below their 52-week high. Century Aluminum earns a 29.7% trailing net margin and trades at 3.0 times EBITDA after a 52% drawdown. The market has already priced a 2027 repeal it cannot yet prove.
The one place the wall does not bite is the AI buildout. The Jan. 14, 2026 proclamation puts a 25% duty on covered advanced computing chips but exempts chips used in U.S. data centers, U.S. research and development, U.S. startups and non-data-center consumer, industrial and public-sector uses in the United States. The Commerce Department went further, saying Taiwanese companies building U.S. capacity may import up to 2.5 times their planned U.S. output without paying Section 232 duties. The chip duty taxes autos and industrial silicon, not the data center — and the data center is where the demand is.
That matters because the AI capital cycle has already turned, with or without a tariff. Tokyo Electron trades at 7.0 times earnings, 48% below its 52-week high, and SK hynix at 4.3 times trailing earnings with quarterly revenue up 328% year over year to 104.6 trillion won and its shares 62% below their 52-week high. A company can grow revenue fourfold and still de-rate, because the market prices what comes after the buildout rather than the buildout itself.
Downstream
Who Actually Pays for the Wall
General Motors shows what a tariff stack does to a margin before it does to a balance sheet. The December 2025 quarter — the first full quarter with the 25% auto and parts duty and the 50% metals duties in force together — produced negative $1.12 billion of gross profit and a $3.33 billion net loss. By the September 2026 quarter gross margin had recovered to 18.5% from negative 2.5%, and operating margin had returned to 7.2%. Pass-through repairs the margin with a lag, while the trailing operating margin of 2.3% on $186.95 billion of revenue shows how much of the stack is still being absorbed.
| Company | Tariff channel | Latest reported | Read-through |
|---|---|---|---|
| General Motors | 25% autos and parts; 50% metals inputs | Q3 2026 gross margin 18.5%; trailing operating margin 2.3% | Recovery is real; the level stays capped |
| Eli Lilly | 100% patented-drug duty; 20% with an onshoring plan | Q3 2026 revenue $24.40B, +38.6% YoY; gross margin 83.9%; trailing capex $10.98B | The onshoring hedge is being bought with capital spending |
| Aluminum Corporation of China | 50% aluminum duty; 12.5% Section 301 rate for China | Trailing net margin 7.8%; 3.1x EV/EBITDA | The U.S. premium outlet closes |
- The 100% default duty on patented drugs is the largest single tariff line in the index, and the 20% rate for qualifying onshoring plans is the escape hatch — Eli Lilly's trailing capital spending of $10.98 billion, more than double the $5.06 billion spent in 2024, is the template for qualifying.
- The two statutes do not stack on the same goods: Section 301's forced-labor duty exempts copper, pharmaceuticals, semiconductors and lumber articles, which already sit under Section 232, so a 2027 attack on one statute leaves the other standing.
- The shock is visible outside the United States too: Mexico's auto exports fell 17.9% year over year in October to 258,137 units, the steepest annual decline since October 2021.
The AI bill
This Is the Pillar Where the New Majority Bites Fastest
Nothing comprehensive passed in 2026, and that is exactly the point: the safety legislation returns to a Senate Commerce Committee that marked up the JAWBONE Act on Sept. 17, with Chair Ted Cruz agreeing to work with ranking member Maria Cantwell on her substitute, which would strip AI models out of the bill and limit liability to government decision-makers. Cantwell followed on Oct. 7 with a six-point framework for frontier models, covering enforceable safety standards, continuous testing, disclosure and independent audits before covered models are released, while H.R. 9477 would require certain model developers to report critical safety incidents to the Commerce Department. The first federal AI safety regime is being written in January, and the states are already running the pilot.
| Vehicle | Status | What it would require | Who pays |
|---|---|---|---|
| JAWBONE Act, Senate Commerce | Marked up Sept. 17, 2026; Chair agreed to refine | Cantwell's substitute removes AI models and limits liability to government decision-makers | Frontier developers and federal agencies |
| Cantwell's frontier framework | Released Oct. 7, 2026 | Enforceable safety standards, continuous testing, independent audits before release | Frontier model developers |
| H.R. 9477, AI Incident Reporting Act | Introduced June 25, 2026 | Critical safety incident reports to the Commerce Department | Frontier model developers |
| New York RAISE Act | Signed Dec. 19, 2025 | Published safety frameworks and 72-hour critical-harm reporting | Frontier model developers |
| House Energy and Commerce and Senate Commerce gavels | New majorities from Jan. 3, 2027 | Hearings, subpoenas and markup authority on model testing and incidents | Hyperscalers, labs and their customers |
- Hearings and subpoenas come before markups: committee gavels in January put lab executives and safety researchers on the record before any bill text is agreed.
- Reporting obligations travel first — incident reports to the Commerce Department and published safety frameworks are cheap to draft, cheap to pass and expensive to ignore.
- Pre-release audits and licensing are the expensive items, and the ones that would actually change how quickly models reach hospitals, insurers and industrial buyers.
- A federal standard would compress the state patchwork, and compliance teams would rebuild calendars once, not twelve times — which is why the bill matters to enterprise buyers before it matters to regulators.
For the large frontier developers the cost is a calendar rather than a rate: an independent audit before release and a 72-hour incident clock change when models ship, in exactly the enterprise and regulated channels that monetize new capability. For the compute chain the demand effect is second-order against a cycle that has already turned — Tokyo Electron on 7.0 times earnings with operating margin at 28.3%, and SK hynix on a 70.3% trailing net margin that the market is nonetheless discounting at 4.3 times earnings.
The money
The Funding Calendar Is Where a Contested Mandate Has Teeth
Treasury told the market on Nov. 2 that it expects to borrow $618 billion in privately-held net marketable debt between October and December, assuming an $850 billion end-December cash balance, and $800 billion in the January-March quarter, assuming a $1.0 trillion end-March balance. The government meanwhile runs on a continuing resolution signed Sept. 2 that expires Dec. 11, 2026, and not one of the twelve FY2027 appropriations bills has passed. The new Congress inherits a Dec. 11 cliff and a $618 billion borrowing quarter it did not arrange.
| Date | Event | Who controls it | What it prices |
|---|---|---|---|
| Dec. 11, 2026 | Continuing resolution expires | Congress, then the President | Shutdown risk running into the transition |
| Jan. 3, 2027 | 120th Congress seated | New Democratic majorities | Who hears the Alaska contest and the Section 232 file |
| Jan. 6, 2027 | Statutory electoral count | Joint session of Congress | Routine; no congressional seats at stake |
| Jan. 20, 2027 | Inauguration | Executive branch | Whether the tariff findings survive a new Congress |
| Feb. 1, 2027 | Prediction-market fallback date | Contract settlement rules | Party of the president pro tempore |
| Mar. 31, 2027 | End of Q1 2027 borrowing | Treasury | $800 billion of new supply |
Long bonds are not pricing any of this. The iShares 20+ Year Treasury Bond ETF trades at $81.92, 9.8% below its 52-week high, on a 2.4 beta — the market has demanded no crisis premium for a December funding fight, which is what you would expect if the base case is another short extension and an argument about riders rather than a shutdown. The asymmetry sits elsewhere: a Democratic House must pass a continuing resolution the President can veto, while the White House wants $618 billion of new borrowing and wants the Section 232 findings left untouched.
Horizons
Two Clocks, Not One
- Days to quarters: the Alaska certification and the Ninth Circuit appeal, the Dec. 11 funding cliff, the first 2027 committee hearings on AI safety, and the Feb. 1 prediction-market fallback.
- One to three years: the Section 232 review file and whether 13 Republican senators defect on a veto override, the renegotiation of pharmaceutical onshoring terms, and whether frontier-model safety rules slow accelerator deployment.
- What would prove this thesis wrong: a Congress that cannot pass a continuing resolution before Dec. 11, or a court striking down a Section 232 determination — either would move the 2027 path faster than any certification fight.
- The certification drama is a headline; the December funding vote and the first 2027 AI markup are the two dates that actually reprice the wall.
Here is the synthesis. The certification fight is real but narrow: the count is not in dispute, the President's legal weapon failed on Nov. 1 and is on appeal, and the only market it can move is a settlement fallback clause. What the fight changes is the politics of the 2027 path, and the direction is counterintuitive — a unified Democratic government is less able to dismantle the tariff wall than it looks, because tariffs are mandatory revenue that reconciliation cannot easily unwind and because a veto override needs Republicans to defect. So the durable trade is not “the tariffs come down on Jan. 20.” It is upstream protection at a compressed multiple, downstream onshoring as a competitive weapon, an AI compliance calendar that slows deployment before it slows revenue, and a funding calendar that hands the President a veto he can trade against the wall.
Where the Contested Mandate Actually Lands
- Steel duties of 25%–50% lifted Q3 2026 gross margin to 20.7% from 13.9%, on revenue up 32% to $11.25 billion.
- Earns a 20.7% gross margin while the finding stands, and a trimmed determination would take most of the 680 basis points of expansion.
- The vote that matters over the next year is the Section 232 review, not the election: a veto override needs 13 Republican senators.
- Trades at 8.8 times trailing EV/EBITDA, 15% below its 52-week high, with domestic hot-rolled coil at $1,135 a ton in July.
- A 25%–50% aluminum duty converts into a 29.7% trailing net margin, net cash and 3.0 times EV/EBITDA on $3.0 billion of sales.
- Rerates from 3.0 times EV/EBITDA if the aluminum finding survives 2027, since the shares already carry a 52% drawdown from their high.
- Quarterly revenue growth of 52% year over year shows the domestic premium widening rather than fading.
- Horizon: days to quarters are an aluminum price call; the one-to-three-year question is whether the finding survives review.
- A 50% aluminum duty plus the 12.5% Section 301 rate for China closes the highest-value export outlet for Chinese primary metal.
- Loses US premium-outlet volume while its own domestic price cycle, not tariffs, sets near-term earnings — hence a bearish rather than capitulating stance.
- At 3.1 times EV/EBITDA, 7.5 times earnings and a 4.9% dividend yield, valuation support limits the damage from a tariff-driven volume loss.
- Horizon: the 2027 Section 232 review is the binary that decides whether the US channel stays shut.
- The 25% auto and parts duty produced negative $1.12 billion of gross profit in Q4 2025; Q3 2026 gross margin had recovered to 18.5%.
- Recovers margin by passing costs through, yet trailing operating margin of 2.3% caps how much of the stack it keeps.
- Bull case: the metals duties it pays are the same duties that lift suppliers' pricing power, including Nucor's. Bear case: a trimmed auto finding cuts its costs and its suppliers' pricing power together.
- Horizon: near-term catalysts are pricing and mix; the one-to-three-year variable is whether the auto finding survives at 25%.
- The 100% default duty on patented drugs is the largest single tariff line in the index, and qualifying onshoring plans get a 20% rate.
- Spends $10.98 billion of trailing capital expenditure — more than double 2024's $5.06 billion — to qualify for the 20% rate.
- Q3 2026 revenue of $24.40 billion was up 38.6% year over year on an 83.9% gross margin, so this is a cost-of-goods question, not a demand question.
- Horizon: the 2027 pharmaceutical determination is the binary, and the onshoring hedge is what protects the margin.
- The 25% chip duty exempts chips used in U.S. data centers, so the tariff lands on autos and industrial silicon rather than AI demand.
- Holds a 75.0% gross margin with no Section 232 duty on data-center sales, leaving tariffs a second-order risk.
- Q2 FY2027 revenue of $96.22 billion on 75.0% gross margin shows the earnings base any AI compliance calendar would have to dent.
- Horizon: a 2027 safety bill bites on deployment timing first, and on silicon orders only if release cadence slips for a full cycle.
- September-quarter revenue rose 328% year over year to 104.6 trillion won, on a 70.3% trailing net margin.
- Trades at 4.3 times trailing earnings and 62% below its 52-week high, so the de-rating is a cycle judgment rather than a tariff judgment.
- Watch item: the first 2027 AI safety markup, which sets the demand narrative, against Korean shipments facing the 12.5% Section 301 rate.
- Horizon: days to quarters are the memory price cycle; the one-to-three-year variable is whether safety rules slow accelerator deployment.
- Treasury expects $618 billion of borrowing in Q4 2026 and $800 billion in Q1 2027, with the continuing resolution expiring Dec. 11.
- Absorbs a funding-premium shock if the Dec. 11 cliff forces a veto standoff in a divided-government year.
- At $81.92 the fund is 9.8% below its 52-week high on a 2.4 beta, so neither a crisis nor the borrowing calendar is priced.
- Watch item: the Dec. 11, 2026 vote, because the long end reprices before the first 2027 appropriation fights rather than after.
